Business
DarioHealth Appoints Seasoned Health Care Executive Jerrod Helms as Chief Commercial Officer
Newly created role will support the accelerating growth of Dario as a leader in the digital therapeutics market NEW YORK, Nov. 15, 2021 /PRNewswire/ --
About this update from Dariohealth Corp.
[{"type":"text","content":"Newly created role will support the accelerating growth of Dario as a leader in the digital therapeutics market\n\n\nNEW YORK, Nov. 15, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the Company appointed Jerrod Helms to the newly created role of Chief Commercial Officer (CCO) to support the rapid expansion of business in the employer, payer, provider and partnership markets that the company has seen over the last quarter and the anticipated acceleration into 2022. Mr. Helms will report to Rick Anderson, President and General Manager North America.\n\"Dario is experiencing significant commercial acceleration as demonstrated by the number of recent customer wins and the expanding opportunity going forward as demand for our multi-chronic digital therapeutic solutions grows in every one of our market segments. Adding Jerrod to our senior leadership team in this new position bolsters our ability to capitalize on our growing opportunities and streamline the organization in recognition of the tremendous company growth over the last year. We are thrilled to welcome him to Dario, and excited about the progress we can make together,\" said Rick Anderson, President and General Manager North America. \nMr. Helms brings a wealth of sales leadership experience in the business-to-business health care markets, with a successful track record of selling to employers and health plans. In his role as CCO, Jerrod will be responsible for all Dario sales channels and partnerships. He joins Dario after most recently serving as Head of Sales at the combined entity of Ginger and Headspace, and he previously held sales leadership roles at Virgin Pulse and Humana.\n\"Dario is at an incredibly exciting stage as momentum in the employer, payer and provider markets swings towards more integrated, highly personalized solutions. Buyers are looking for integrated, user-centric solutions that deliver better value, and I believe Dario is poised to accelerate growth significantly,\" said Jerrod Helms.\nAbout DarioHealth Corp.\nDarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market - covering mu...